Insights

Key Personnel Promotion Henry Pelish promoted to Chief Scientific Officer, indicating potential for collaboration and engagement.

Strategic Acquisition Hudson Bay Capital Management LP acquires Nuvalent, suggesting interest in the company's offerings and potential for partnership.

Clinical Trial Advancement Phase 2 portion of ALKOVE-1 trial initiated on NVL-655 for ALK-positive NSCLC, presenting a chance for future drug procurement deals.

Financial Investment Arizona State Retirement System invests $243K in Nuvalent, signaling trust in the company's growth and potential sales opportunities.

Public Offering Nuvalent went public, highlighting market interest and potential for increased visibility leading to business partnerships.

Similar companies to Nuvalent, Inc.

Nuvalent, Inc. Tech Stack

Nuvalent, Inc. uses 8 technology products and services including LinkedIn Recruiter, SAS, SAS/GRAPH, and more. Explore Nuvalent, Inc.'s tech stack below.

LinkedIn Recruiter
Applicant Tracking Systems
SAS
Business Intelligence
SAS/GRAPH
Business Intelligence
Cloudflare
Content Management System
Font Awesome
Font Scripts
WP Engine
Platform As A Service
Smartsheet
Project Management
Genesis theme
Web Platform Extensions

Media & News

Nuvalent, Inc.'s Email Address Formats

Nuvalent, Inc. uses at least 1 format(s):

Nuvalent, Inc. Email Formats	Example	Percentage
FLast@nuvalent.com	JDoe@nuvalent.com	32%
First.Last@nuvalent.com	John.Doe@nuvalent.com	18%
FLast@nuvalent.com	JDoe@nuvalent.com	32%
First.Last@nuvalent.com	John.Doe@nuvalent.com	18%

Frequently Asked Questions

Where is Nuvalent, Inc.'s headquarters located?

Nuvalent, Inc.'s main headquarters is located at One Broadway 14th Floor Cambridge, Massachusetts 02142 US. The company has employees across 1 continents, including North America.

What is Nuvalent, Inc.'s stock symbol?

Nuvalent, Inc. is a publicly traded company; the company's stock symbol is NUVL.

What is Nuvalent, Inc.'s official website and social media links?

Nuvalent, Inc.'s official website is nuvalent.com and has social profiles on LinkedIn.

How much revenue does Nuvalent, Inc. generate?

As of September 2024, Nuvalent, Inc.'s annual revenue reached $3.8M.

What is Nuvalent, Inc.'s SIC code NAICS code?

Nuvalent, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nuvalent, Inc. have currently?

As of September 2024, Nuvalent, Inc. has approximately 132 employees across 1 continents, including North America. Key team members include Chief Scientific Officer: H. P.Vice President Global Regulatory Affairs: V. V.Vice President Financial Planning & Analysis: B. V.. Explore Nuvalent, Inc.'s employee directory with LeadIQ.

What industry does Nuvalent, Inc. belong to?

Nuvalent, Inc. operates in the Biotechnology Research industry.

What technology does Nuvalent, Inc. use?

Nuvalent, Inc.'s tech stack includes LinkedIn RecruiterSASSAS/GRAPHCloudflareFont AwesomeWP EngineSmartsheetGenesis theme.

What is Nuvalent, Inc.'s email format?

Nuvalent, Inc.'s email format typically follows the pattern of . Find more Nuvalent, Inc. email formats with LeadIQ.

How much funding has Nuvalent, Inc. raised to date?

As of September 2024, Nuvalent, Inc. has raised $575M in funding. The last funding round occurred on Sep 16, 2024 for $575M.

When was Nuvalent, Inc. founded?

Nuvalent, Inc. was founded in 2017.

Nuvalent, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.

Company Overview

Headquarters: One Broadway 14th Floor Cambridge, Massachusetts 02142 US
Website: nuvalent.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: NUVL
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2017
Employees: 51-200

Media & News

Funding & Financials

$575M
Nuvalent, Inc. has raised a total of $575M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2024 in the amount of $575M.
$10M
Nuvalent, Inc.'s revenue is in the range of $10M

Funding & Financials

$575M
Nuvalent, Inc. has raised a total of $575M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2024 in the amount of $575M.
$10M
Nuvalent, Inc.'s revenue is in the range of $10M

Company Leadership

H. P.
Chief Scientific Officer
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. V.
Vice President Global Regulatory Affairs
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. V.
Vice President Financial Planning & Analysis
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. Z.
Vice President Of Clinical Development
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. D.
Head Of Talent Acquisition
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

V. U.
Vice President, Clinical Development
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. L.
Senior Vp, Technical Operations
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Vp, Accounting
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. S.
Senior Vice President, Translational Development (nonclinical Development And Clinical Pharmacology)
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
B. V.
Vice President Financial Planning & Analysis
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Nuvalent, Inc. and Millions of Other Companies
Sign up for full access to Nuvalent, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Nuvalent, Inc.

Iterum Therapeutics plc

Nabriva Therapeutics plc

BerGenBio ASA

Nuvalent, Inc. Tech Stack

Media & News

Nuvalent, Inc. promotes Henry Pelish to Chief Scientific Officer.

Hudsonbaycapital acquires Nuvalent, Inc..

Nuvalent, Inc. launched Phase 2 portion of ALKOVE-1 clinical trial on Feb 12th '24.

Nuvalent, Inc. launches OnTarget 2026.

Azasrs invests into Nuvalent, Inc. $243K.

Nuvalent, Inc. has issues with : breaking ground in Cancer therapy.

Nuvalent, Inc. went public on Oct 4th '22.

Nuvalent, Inc.'s Email Address Formats

Frequently Asked Questions

Where is Nuvalent, Inc.'s headquarters located?

What is Nuvalent, Inc.'s stock symbol?

What is Nuvalent, Inc.'s official website and social media links?

How much revenue does Nuvalent, Inc. generate?

What is Nuvalent, Inc.'s SIC code NAICS code?

How many employees does Nuvalent, Inc. have currently?

What industry does Nuvalent, Inc. belong to?

What technology does Nuvalent, Inc. use?

What is Nuvalent, Inc.'s email format?

How much funding has Nuvalent, Inc. raised to date?

When was Nuvalent, Inc. founded?

Nuvalent, Inc.

Company Overview

Media & News

Nuvalent, Inc. promotes Henry Pelish to Chief Scientific Officer.

Hudsonbaycapital acquires Nuvalent, Inc..

Nuvalent, Inc. launched Phase 2 portion of ALKOVE-1 clinical trial on Feb 12th '24.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?